PureTech Health plc (LON:PRTC)
131p-0.30%
Spriggl Score: Moderate— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Seaport stake exceeds market cap while clinical data de-risks platform; holding-company discount persists despite strong cash buffer.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About PureTech Health plc
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, a Phase 3-ready therapeutic candidate with the potential to establish a new standard of care (SOC) for the treatment…
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- £321.3M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across PureTech Health plc and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free